163 related articles for article (PubMed ID: 21344648)
1. New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors.
Ronco C; Foucault R; Gillon E; Bohn P; Nachon F; Jean L; Renard PY
ChemMedChem; 2011 May; 6(5):876-88. PubMed ID: 21344648
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.
Camps P; Formosa X; Muñoz-Torrero D; Petrignet J; Badia A; Clos MV
J Med Chem; 2005 Mar; 48(6):1701-4. PubMed ID: 15771413
[TBL] [Abstract][Full Text] [Related]
3. Screening of new huprines--inhibitors of acetylcholinesterases by electrospray ionization ion trap mass spectrometry.
Ziemianin A; Ronco C; Dolé R; Jean L; Renard PY; Lange CM
J Pharm Biomed Anal; 2012 Nov; 70():1-5. PubMed ID: 22677656
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of Huprine derivatives as human acetylcholinesterase inhibitors.
Ronco C; Sorin G; Nachon F; Foucault R; Jean L; Romieu A; Renard PY
Bioorg Med Chem; 2009 Jul; 17(13):4523-36. PubMed ID: 19473849
[TBL] [Abstract][Full Text] [Related]
5. 3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates.
Dvir H; Wong DM; Harel M; Barril X; Orozco M; Luque FJ; Muñoz-Torrero D; Camps P; Rosenberry TL; Silman I; Sussman JL
Biochemistry; 2002 Mar; 41(9):2970-81. PubMed ID: 11863435
[TBL] [Abstract][Full Text] [Related]
6. Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
Galdeano C; Viayna E; Sola I; Formosa X; Camps P; Badia A; Clos MV; Relat J; Ratia M; Bartolini M; Mancini F; Andrisano V; Salmona M; Minguillón C; González-Muñoz GC; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Muñoz-Torrero D
J Med Chem; 2012 Jan; 55(2):661-9. PubMed ID: 22185619
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids.
Alcalá Mdel M; Vivas NM; Hospital S; Camps P; Muñoz-Torrero D; Badia A
Neuropharmacology; 2003 May; 44(6):749-55. PubMed ID: 12681373
[TBL] [Abstract][Full Text] [Related]
8. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
Camps P; Cusack B; Mallender WD; El Achab RE; Morral J; Muñoz-Torrero D; Rosenberry TL
Mol Pharmacol; 2000 Feb; 57(2):409-17. PubMed ID: 10648652
[TBL] [Abstract][Full Text] [Related]
9. Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy.
Mezeiova E; Korabecny J; Sepsova V; Hrabinova M; Jost P; Muckova L; Kucera T; Dolezal R; Misik J; Spilovska K; Pham NL; Pokrievkova L; Roh J; Jun D; Soukup O; Kaping D; Kuca K
Molecules; 2017 Jul; 22(8):. PubMed ID: 28788095
[TBL] [Abstract][Full Text] [Related]
10. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
[TBL] [Abstract][Full Text] [Related]
11. Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis.
Galdeano C; Coquelle N; Cieslikiewicz-Bouet M; Bartolini M; Pérez B; Clos MV; Silman I; Jean L; Colletier JP; Renard PY; Muñoz-Torrero D
Molecules; 2018 Mar; 23(3):. PubMed ID: 29534488
[TBL] [Abstract][Full Text] [Related]
12. Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography.
Ronco C; Carletti E; Colletier JP; Weik M; Nachon F; Jean L; Renard PY
ChemMedChem; 2012 Mar; 7(3):400-5. PubMed ID: 22052791
[No Abstract] [Full Text] [Related]
13. Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Pérez-Areales FJ; Di Pietro O; Espargaró A; Vallverdú-Queralt A; Galdeano C; Ragusa IM; Viayna E; Guillou C; Clos MV; Pérez B; Sabaté R; Lamuela-Raventós RM; Luque FJ; Muñoz-Torrero D
Bioorg Med Chem; 2014 Oct; 22(19):5298-307. PubMed ID: 25156301
[TBL] [Abstract][Full Text] [Related]
14. Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Bosak A; Opsenica DM; Šinko G; Zlatar M; Kovarik Z
Chem Biol Interact; 2019 Aug; 308():101-109. PubMed ID: 31100281
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro pharmacology, and molecular modeling of syn-huprines as acetylcholinesterase inhibitors.
Camps P; Gómez E; Muñoz-Torrero D; Badia A; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 2001 Dec; 44(26):4733-6. PubMed ID: 11741490
[TBL] [Abstract][Full Text] [Related]
17. New potent acetylcholinesterase inhibitors in the tetracyclic triterpene series.
Sauvaître T; Barlier M; Herlem D; Gresh N; Chiaroni A; Guenard D; Guillou C
J Med Chem; 2007 Nov; 50(22):5311-23. PubMed ID: 17902635
[TBL] [Abstract][Full Text] [Related]
18. Binding of 13-amidohuprines to acetylcholinesterase: exploring the ligand-induced conformational change of the gly117-gly118 peptide bond in the oxyanion hole.
Camps P; Gómez E; Muñoz-Torrero D; Badia A; Clos MV; Curutchet C; Muñoz-Muriedas J; Luque FJ
J Med Chem; 2006 Nov; 49(23):6833-40. PubMed ID: 17154513
[TBL] [Abstract][Full Text] [Related]
19. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of α-oxycarbanilinophosphonates and their anticholinesterase activities: the most potent derivative is bound to the peripheral site of acetylcholinesterase.
Kaboudin B; Emadi S; Faghihi MR; Fallahi M; Sheikh-Hasani V
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):576-82. PubMed ID: 22397393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
